Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
4,92 USD | +1,23% | +2,50% | -44,47% |
Omzet 2024 * | 14,43 mln. 13,52 mln. | Omzet 2025 * | 14,72 mln. 13,79 mln. | Marktkapitalisatie | 560 mln. 525 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -218 mln. -204 mln. | Nettowinst (verlies) 2025 * | -223 mln. -209 mln. | EV/omzet 2024 * | 31,3 x |
Nettoliquiditeiten 2024 * | 109 mln. 102 mln. | Nettoliquiditeiten 2025 * | 275 mln. 258 mln. | EV/omzet 2025 * | 19,4 x |
K/w-verhouding 2024 * |
-2,63
x | K/w-verhouding 2025 * |
-3
x | Werknemers | 234 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 74,98% |
Recentste transcriptie over Prime Medicine, Inc.
1 dag | +1,23% | ||
1 week | +2,50% | ||
Lopende maand | -29,71% | ||
1 maand | -27,22% | ||
3 maanden | -27,54% | ||
6 maanden | -15,46% | ||
Lopend jaar | -44,47% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 70 | 01-07-20 | |
Allan Reine
DFI | Director of Finance/CFO | 49 | 17/01 |
Chief Operating Officer | 52 | 01-09-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 64 | 01-12-21 | |
Robert Nelsen
BRD | Director/Board Member | 60 | 01-09-20 |
Michael Kelly
BRD | Director/Board Member | 67 | 01-11-21 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
4.71% | 2 M€ | -25,75% | ||
0.00% | 9 M€ | +5,66% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
30-04-24 | 4,92 | +1,23% | 1 202 438 |
29-04-24 | 4,86 | +9,83% | 1 268 471 |
26-04-24 | 4,425 | +2,91% | 641 595 |
25-04-24 | 4,3 | -8,51% | 848 913 |
24-04-24 | 4,7 | -2,08% | 522 474 |
uitgestelde koers Nasdaq, 30 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-44,47% | 560 mln. | |
-3,46% | 102 mld. | |
+1,41% | 96,29 mld. | |
+2,13% | 22,18 mld. | |
-15,84% | 21,2 mld. | |
-9,21% | 18,31 mld. | |
-39,98% | 17,38 mld. | |
-14,65% | 16,36 mld. | |
+4,39% | 13,97 mld. | |
+31,35% | 12,17 mld. |